2009
DOI: 10.1007/s10552-009-9441-9
|View full text |Cite
|
Sign up to set email alerts
|

Medical history, body size, and cigarette smoking in relation to fatal prostate cancer

Abstract: The observed increase in risk associated with recent cigarette smoking is consistent with the findings of several other studies. However, in contrast with some reports, we observed no connection between fatal prostate cancer and some prior health conditions or measures of body size.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
11
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(12 citation statements)
references
References 54 publications
(79 reference statements)
1
11
0
Order By: Relevance
“…Heavy smokers had an increased risk of dying from prostate cancer, which is consistent with findings from previous US studies (Hsing et al , 1990; Hsing et al , 1991; Coughlin et al , 1996; Rodriguez et al , 1997; Giovannucci et al , 1999; Giovannucci et al , 2007; Rohrmann et al , 2007; Batty et al , 2008; Watters et al , 2009; Weinmann et al , 2010). Zu and Giovannucci (2009) concluded that, compared with never smokers, current smoking is associated with an increased risk of about 30% for fatal prostate cancer; depending on the comparison, the increase in risk ranges from 14% to 30% in the meta-analysis of Huncharek et al , (2010).…”
Section: Discussionsupporting
confidence: 90%
“…Heavy smokers had an increased risk of dying from prostate cancer, which is consistent with findings from previous US studies (Hsing et al , 1990; Hsing et al , 1991; Coughlin et al , 1996; Rodriguez et al , 1997; Giovannucci et al , 1999; Giovannucci et al , 2007; Rohrmann et al , 2007; Batty et al , 2008; Watters et al , 2009; Weinmann et al , 2010). Zu and Giovannucci (2009) concluded that, compared with never smokers, current smoking is associated with an increased risk of about 30% for fatal prostate cancer; depending on the comparison, the increase in risk ranges from 14% to 30% in the meta-analysis of Huncharek et al , (2010).…”
Section: Discussionsupporting
confidence: 90%
“…In analyses limited to aggressive prostate cancer, some evidence of a null association was seen (OR=1.03), although small sample sizes rendered this estimate unreliable. Null associations were also found in studies investigating advanced stage (T 3b or worse; OR=0.81; 95% CI: 0.50-1.30; 29 ) and fatal prostate cancer (OR=1.0; 95% CI: 0.79-1.4 14 ). No appreciable differences were observed in the overall pooled estimate when we excluded studies that either enriched 31,32 or depleted 13,15,16,18,20,[33][34][35] their control populations of prostate conditions (e.g., BPH, high PSA, all benign prostate conditions).…”
Section: Resultsmentioning
confidence: 77%
“…When multiple articles from the same study population were found, the most recent or complete publication was included. One exception was two studies performed among health plan members at Kaiser Permanente 13,14 . Although these studies overlapped by some years of enrollment, we retained both studies because of their likely minimal overlap in study participants as Weinmann et.…”
Section: Search Strategymentioning
confidence: 99%
“…Exclusion of Hosseini 2010 from meta-analysis decreased the I 2 value to 81% ('substantial' heterogeneity). The Weinmann 2010 study differed from all other thirteen studies, as it included only lethal prostate cancer cases (19). However, tentative exclusion of this study from the meta-analysis did not modify the I 2 value (I 2 = 91%).…”
Section: Resultsmentioning
confidence: 97%